首页> 外文期刊>BMC Complementary and Alternative Medicine >Effects of the combined extracts of Herba Epimedii and Fructus Ligustrilucidi on airway remodeling in the asthmatic rats with the treatment of budesonide
【24h】

Effects of the combined extracts of Herba Epimedii and Fructus Ligustrilucidi on airway remodeling in the asthmatic rats with the treatment of budesonide

机译:淫羊and和五味子联合提取物对布地奈德治疗对哮喘大鼠气道重塑的影响

获取原文
       

摘要

Background Asthma is characterized by chronic airway inflammation, leading to structura1 changes in the airway, collectively termed airway remodeling. Airway remodeling is thought to contribute to airway hyper responsiveness and irreversible airflow limitation. The combination of Herba Epimedii (HE) and Fructus Ligustri Lucidi (FLL) decoction and the systemic administration of glucocorticoids (GC) had a synergistic inhibitory action on airway inflammation in the asthmatic model rats. However, the effects of the combination on airway remodeling have not been studied and compared. In the present study, we investigated the effects of the co-administration of combined extracts of HE and FLL with inhaled GC (budesonide) on airway remodeling in the rat asthmatic model induced by ovalbumin (OVA). Methods Male Sprague-Dawley rats were sensitized to intraperitoneal OVA followed by repetitive OVA challenge for 7?weeks. Treatments included extracts of HE and FLL (Extracts for short, 100?mg/kg by gastric perfusion), budesonide (1?mg budesonide suspension in 50?ml sterile physiological saline, 3 rats in an ultrasonic nebulizer by nebulized inhabation with a flow of 1.6?ml/min for 30?min), and co-administration of extracts of HE and FLL with budesonide (Co-administration for short) for 4?weeks. Lung histomorphometry and bronchoalveolar lavage fluid (BALF) cell count were assessed 24?h after the final OVA challenge. Levels of interleukin (IL)-4, IL-5 and IgE were measured by ELISA. Expressions of Collagen I and Collagen III were tested by immunohistology. Expressions of transforming growth factor (TGF) -β1, TGF-β2 and Smads mRNA were measured by quantitative real-time PCR. Results Extracts, budesonide and Co-administration significantly reduced allergen-induced increases in the serum levels of IL-4, IL-5 and IgE, the number of eosinophils in BALF, goblet cell hyperplasia, Collagen III integral optical density (IOD) and the mRNA expression of TGF-β2 and Smad2. Extracts and Co-administration could depress the IOD level of Collagen I and the positive area of Collagen I and Collagen III. Budesonide and Co-administration significantly alleviated the thickening of airway wall. Only Co-administration significantly decreased collagen deposition according to the morphometry of Masson’s-stained lung sections, the thickening of airway smooth muscle layer, the number of lymphocytes in BALF and the mRNA expression of TGF-β1 and Smad3, and this was associated with a significant increase in levels of Smad7 mRNA. Conclusions The findings suggested that the combination of budesonide and the herbal extracts had a better synergistic effect on airway remodeling in OVA-reduced asthma rats than the single use of budesonide.
机译:背景哮喘的特征是慢性气道炎症,导致气道结构改变,统称为气道重塑。气道重塑被认为有助于气道高反应性和不可逆的气流受限。淫羊Epi(HE)和山茱Luc(FLL)汤联合全身应用糖皮质激素(GC)对哮喘模型大鼠的气道炎症具有协同抑制作用。但是,该组合对气道重塑的影响尚未得到研究和比较。在本研究中,我们研究了HE和FLL联合提取物与吸入GC(布地奈德)的共同给药对卵白蛋白(OVA)诱导的大鼠哮喘模型气道重塑的影响。方法雄性Sprague-Dawley大鼠先对腹膜内OVA敏感,然后重复OVA攻击7周。处理方法包括HE和FLL提取物(简称为提取物,通过胃灌流提取100?mg / kg),布地奈德(1?mg布地奈德悬浮于50?ml无菌生理盐水中),3只大鼠在超声雾化器中通过雾化吸入并用1.6?ml / min,持续30?min),HE和FLL提取物与布地奈德共同给药(简称共同给药),持续4周。在最后一次OVA攻击后24小时,评估肺组织形态计量学和支气管肺泡灌洗液(BALF)细胞计数。通过ELISA测量白介素(IL)-4,IL-5和IgE的水平。通过免疫组织学测试胶原蛋白I和胶原蛋白III的表达。通过定量实时PCR检测转化生长因子(TGF)-β1,TGF-β2和Smads mRNA的表达。结果提取物,布地奈德和共同给药可显着降低变应原诱导的血清IL-4,IL-5和IgE水平升高,BALF中嗜酸性粒细胞数量,杯状细胞增生,胶原III积分光密度(IOD)和TGF-β2和Smad2的mRNA表达。提取物和共同给药可降低I型胶原蛋白的IOD水平以及I型胶原蛋白和III型胶原蛋白的阳性区域。布地奈德和共同给药可显着减轻气道壁增厚。根据马氏染色肺切片的形态,气道平滑肌层的增厚,BALF中淋巴细胞的数量以及TGF-β1和Smad3的mRNA表达,只有共同给药才能显着减少胶原蛋白的沉积。 Smad7 mRNA水平显着增加。结论研究结果表明,布地奈德与草药提取物的组合对OVA降低的哮喘大鼠的气道重塑具有比单次使用布地奈德更好的协同作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号